Gujarat Themis Biosyn Ltd approves Q2 FY27 results, reporting ₹8.47 crore standalone profit and ₹13.84 crore consolidated loss
- Standalone revenue was ₹47.46 crore (+12.1% YoY); net profit fell 40.6% YoY, with a 37.4% EBITDA margin.
- Consolidated revenue was ₹49.92 crore (+17.9% YoY); results included a ₹1.17 crore earthquake-related subsidiary loss.
- Company Secretary and Compliance Officer Vineet Gawankar will resign effective 30 November 2026.
